Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment

Clinical trial NCT04874948 · COMPLETED

Trial details

NCT number: NCT04874948
Sponsor: Michael Hoelscher
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tuberculosis Tuberculosis, Pulmonary Bacterial Infections Respiratory Lung Diseases Mycobacterium Infections

Start date: 2021-10-08
Primary completion: 2021-10-15
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.